Surgery Partners Stock Number Of Employees

SGRY Stock  USD 24.39  0.03  0.12%   
Surgery Partners fundamentals help investors to digest information that contributes to Surgery Partners' financial success or failures. It also enables traders to predict the movement of Surgery Stock. The fundamental analysis module provides a way to measure Surgery Partners' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Surgery Partners stock.
Short Long Term Debt TotalTotal Assets
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Surgery Partners Company Number Of Employees Analysis

Surgery Partners' Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Number of Employees

 = 

Full Time

+

Part Time

More About Number Of Employees | All Equity Analysis

Current Surgery Partners Number Of Employees

    
  15 K  
Most of Surgery Partners' fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgery Partners is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Surgery Number Of Employees Driver Correlations

Understanding the fundamental principles of building solid financial models for Surgery Partners is extremely important. It helps to project a fair market value of Surgery Stock properly, considering its historical fundamentals such as Number Of Employees. Since Surgery Partners' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Surgery Partners' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Surgery Partners' interrelated accounts and indicators.
0.830.56-0.750.970.980.991.00.890.980.970.590.920.00.050.890.960.760.810.950.790.50.58-0.69
0.830.21-0.810.880.730.840.810.640.830.770.360.90.150.30.910.810.90.650.740.980.630.79-0.93
0.560.21-0.110.40.60.510.560.710.520.650.490.34-0.01-0.370.290.360.130.460.560.07-0.08-0.08-0.08
-0.75-0.81-0.11-0.82-0.72-0.8-0.71-0.55-0.79-0.73-0.34-0.89-0.26-0.5-0.79-0.72-0.81-0.73-0.67-0.88-0.58-0.740.83
0.970.880.4-0.820.920.980.950.760.960.920.480.920.060.20.960.960.890.760.890.860.630.71-0.78
0.980.730.6-0.720.920.970.980.910.970.960.660.89-0.030.00.80.930.640.830.960.70.390.48-0.59
0.990.840.51-0.80.980.970.980.850.990.950.580.920.050.10.90.950.80.790.920.80.530.63-0.72
1.00.810.56-0.710.950.980.980.90.970.950.620.9-0.05-0.010.870.960.720.810.960.760.470.54-0.65
0.890.640.71-0.550.760.910.850.90.870.890.570.79-0.02-0.180.660.780.480.770.910.570.210.36-0.49
0.980.830.52-0.790.960.970.990.970.870.950.540.910.130.160.880.940.790.790.940.80.460.67-0.73
0.970.770.65-0.730.920.960.950.950.890.950.510.920.020.090.840.910.690.850.960.720.440.48-0.63
0.590.360.49-0.340.480.660.580.620.570.540.510.45-0.24-0.330.330.480.180.340.470.310.180.07-0.19
0.920.90.34-0.890.920.890.920.90.790.910.920.450.060.280.890.90.790.850.890.910.580.63-0.8
0.00.15-0.01-0.260.06-0.030.05-0.05-0.020.130.02-0.240.060.48-0.02-0.090.27-0.1-0.020.18-0.380.53-0.48
0.050.3-0.37-0.50.20.00.1-0.01-0.180.160.09-0.330.280.480.260.140.430.130.060.430.280.58-0.47
0.890.910.29-0.790.960.80.90.870.660.880.840.330.89-0.020.260.90.940.710.80.890.780.73-0.79
0.960.810.36-0.720.960.930.950.960.780.940.910.480.9-0.090.140.90.770.790.940.790.580.6-0.65
0.760.90.13-0.810.890.640.80.720.480.790.690.180.790.270.430.940.770.540.630.90.70.89-0.9
0.810.650.46-0.730.760.830.790.810.770.790.850.340.85-0.10.130.710.790.540.880.670.40.34-0.53
0.950.740.56-0.670.890.960.920.960.910.940.960.470.89-0.020.060.80.940.630.880.710.360.48-0.6
0.790.980.07-0.880.860.70.80.760.570.80.720.310.910.180.430.890.790.90.670.710.650.82-0.94
0.50.63-0.08-0.580.630.390.530.470.210.460.440.180.58-0.380.280.780.580.70.40.360.650.45-0.45
0.580.79-0.08-0.740.710.480.630.540.360.670.480.070.630.530.580.730.60.890.340.480.820.45-0.89
-0.69-0.93-0.080.83-0.78-0.59-0.72-0.65-0.49-0.73-0.63-0.19-0.8-0.48-0.47-0.79-0.65-0.9-0.53-0.6-0.94-0.45-0.89
Click cells to compare fundamentals
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Competition

Based on the recorded statements, Surgery Partners is currently employing 15 K people. This is 36.4% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The number of employees for all United States stocks is 20.39% higher than that of the company.

Surgery Number Of Employees Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgery Partners' direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Surgery Partners could also be used in its relative valuation, which is a method of valuing Surgery Partners by comparing valuation metrics of similar companies.
15.0K76.0K35.3K39.3K100%
Surgery Partners is currently under evaluation in number of employees category among its peers.

Surgery Partners ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Surgery Partners' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Surgery Partners' managers, analysts, and investors.
64.4%
Environmental
59.7%
Governance
Social

Surgery Fundamentals

Return On Equity0.0036
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-500%0%500%1,000%
Return On Asset0.0401
Profit Margin(0.05) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-2,000%-1,500%-1,000%-500%0%
Operating Margin0.20 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Current Valuation6.54 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%10%20%30%
Shares Outstanding127.61 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%10,000%12,000%
Shares Owned By Insiders1.47 %
Shares Owned By Institutions98.53 %
Number Of Shares Shorted10.25 M
Price To Earning61.84 X
Price To Book1.74 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-1,000%-500%0%500%1,000%1,500%2,000%
Price To Sales1.00 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Revenue3.11 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%
Gross Profit745.6 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%500%600%
EBITDA501.4 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%500%600%
Net Income12.5 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-10,000%-5,000%0%5,000%
Cash And Equivalents227.4 M
Cash Per Share2.58 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%
Total Debt393.5 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100%200%300%400%500%600%
Debt To Equity1.44 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-4,000%-2,000%0%2,000%4,000%6,000%8,000%
Current Ratio1.51 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-30%-25%-20%-15%-10%-5%
Book Value Per Share14.18 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-10,000%-8,000%-6,000%-4,000%-2,000%
Cash Flow From Operations300.1 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100%200%300%400%500%
Short Ratio5.82 X
Earnings Per Share(1.33) X
Price To Earnings To Growth1.66 X
Target Price31.91
Number Of Employees15 K
Beta2.74
Market Capitalization3.11 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100%200%300%400%
Total Asset7.89 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%
Retained Earnings(737.3 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100%200%300%
Working Capital495 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Current Asset310.96 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%1,200%
Current Liabilities181.29 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%1,200%1,400%
Net Asset7.89 B

About Surgery Partners Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Surgery Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgery Partners using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgery Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.